Re: “Assessing the Detection of Middle East Respiratory Syndrome Coronavirus IgG in Suspected and Proven Cases of Middle East Respiratory Syndrome Coronavirus Infection” by Alhetheel et al. (Viral Immunol 2017;30:649–653.)
Restricted accessLetterFirst published online December, 2017
Re: “Assessing the Detection of Middle East Respiratory Syndrome Coronavirus IgG in Suspected and Proven Cases of Middle East Respiratory Syndrome Coronavirus Infection” by Alhetheel et al. (Viral Immunol 2017;30:649–653.)
AlhetheelA, AltalhiH, AlbarragA, et al.Assessing the detection of Middle East respiratory syndrome coronavirus IgG in suspected and proven cases of Middle East respiratory syndrome coronavirus infection. Viral Immunol, 2017; 30:649–653.
2.
KimCJ, ChoiWS, JungY, et al.Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity. Clin Microbiol Infect, 2016; 22:880–886.
3.
WangJ, MeadeJR, BrownNK, et al.EDTA is superior to DTT treatment for overcoming the prozone effect in HLA antibody testing. HLA, 2017; 89:82–89.
